Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,832.41 -44.64 (-0.57%) Bitcoin USD
64,678.74 +2,994.32 (+4.85%) CMC Crypto 200
1,334.47 +21.84 (+1.69%)
Innoviva, Inc. (INVA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 14.48 |
| Open | 14.49 |
| Bid | 14.68 x 200 |
| Ask | 14.70 x 300 |
| Day's range | 14.44 - 14.71 |
| 52-week range | 11.37 - 16.86 |
| Volume | |
| Avg. volume | 676,020 |
| Market cap | 928.809M |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 6.68 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 08 Sept 2015 |
| 1y target est | N/A |
- GuruFocus.com
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
Company Sees 35% Year-Over-Year Growth in Q4 Product Revenues
- GuruFocus.com
Jim Simons Bolsters Position in Innoviva Inc with Recent Acquisition
Overview of the Recent Portfolio Addition Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently expanded its investment portfolio with the addition of 4,144,447 shares in Innoviva Inc (NASDAQ:INVA). The transaction, which took place on December 29, 2023, reflects a 3.63% increase from the previous holding, marking a significant vote of confidence in the biopharmaceutical company. With a trade price of $16.04 per share, the firm has demonstrated a strategic move to capitalize on Innoviva's market potential.
- Simply Wall St.
Innoviva's (NASDAQ:INVA) investors will be pleased with their 29% return over the last three years
One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...
© 2024 Yahoo. All rights reserved.